ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 55 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -25.8% | 11,000 | -22.5% | 0.00% | – |
| Q3 2019 | $31,000 | -8.8% | 14,200 | +5.2% | 0.00% | – |
| Q2 2019 | $34,000 | -67.3% | 13,500 | -55.0% | 0.00% | – |
| Q1 2019 | $104,000 | +52.9% | 30,000 | +1.7% | 0.00% | – |
| Q4 2018 | $68,000 | +17.2% | 29,500 | +96.7% | 0.00% | – |
| Q3 2018 | $58,000 | -72.6% | 15,000 | -67.4% | 0.00% | – |
| Q3 2017 | $212,000 | +118.6% | 46,000 | +2.2% | 0.00% | – |
| Q2 2017 | $97,000 | -31.7% | 45,000 | 0.0% | 0.00% | – |
| Q1 2017 | $142,000 | +21.4% | 45,000 | 0.0% | 0.00% | – |
| Q4 2016 | $117,000 | +20.6% | 45,000 | +80.0% | 0.00% | – |
| Q3 2016 | $97,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |